Article Figures & Data
Tables
HMs subtypes Male Female Total B-ALL 74 (61.2) 47 (38.8) 121 (70.3) AML-M4 8 (53.3) 7 (46.7) 15 (8.7) T-ALL 8 (100) 0 (0) 8 (4.7) AML-M3 4 (66.7) 2 (33.3) 6 (3.5) AML-M5 2 (50.0) 2 (50.0) 4 (2.3) MPAL 2 (50.0) 2 (50.0) 4 (2.3) JMML 3 (100) 0 (0) 3 (1.7) MDS 3 (100) 0 (0) 3 (1.7) AML-M2 1 (50.0) 1 (50.0) 2 (1.2) AML-M6 1 (50.0) 1 (50.0) 2 (1.2) Burkitt’s lymphoma 2 (100) 0 (0) 2 (1.2) Prolymphocytic leukemia 1 (100) 0 (0) 1 (0.6) Total 109 (64.0) 62 (36) 171 (100) Values are presented as number and percentages (%). HMs: hematological malignancies, B-ALL: B-cell acute lymphoblastic leukemia, AML-M4: myelomonocytic leukemia, T-ALL: T-cell acute lymphoblastic leukemia, AML-M3: Acute promyelocytic leukemia, AML-M5: acute monoblastic leukemia, MPAL: mixed-phenotype acute leukemia, JMML: juvenile myelo-monocytic leukemia, MDS: myelodysplastic syndrome, AML-M2: acute myeloid leukemia with maturation, AML-M6: acute erythroid leukemia
- Table 2
- Distribution of hematological malignancies (HMs) cases according to subtypes and age. Early childhood (≤5 years old), Middle childhood (6–12 years old), and late childhood (13–16 years old).
HMs subtypes Early childhood Middle childhood Late childhood B-ALL 81 (66.9) 35 (28.9) 5 (4.2) AML-M4 10 (66.6) 4 (26.7) 1 (6.7) T-ALL 4 (50.0) 3 (37.5) 1 (12.5) AML-M3 3 (50.0) 3 (50.0) 0 (0) AML-M5 3 (75.0) 0 (0) 1 (25.0) MPAL 1 (25.0) 2 (50.0) 1 (25.0) JMML 3 (100) 0 (0) 0 (0) MDS 2 (66.6) 1 (33.3) 0 (0) AML-M2 1 (50.0) 1 (50) 0 (0) AML-M6 1 (50.0) 1 (50) 0 (0) Burkitt’s lymphoma 1 (50.0) 1 (50) 0 (0) Prolymphocytic leukemia 1 (100) 0 (0) 0 (0) Total 111 (65.1) 51 (29.8) 9 (5.3) Values are presented as number and percentages (%). HMs: hematological malignancies, B-ALL: B-cell acute lymphoblastic leukemia, AML-M4: myelomonocytic leukemia, T-ALL: T-cell acute lymphoblastic leukemia, AML-M3: Acute promyelocytic leukemia, AML-M5: acute monoblastic leukemia, MPAL: Mixed-phenotype acute leukemia, JMML: juvenile myelo-monocytic leukemia, MDS: myelodysplastic syndrome, AML-M2: acute myeloid leukemia with maturation, AML-M6: acute erythroid leukemia